TrialNature cancer2026

Axicabtagene ciloleucel in combination with rituximab for refractory large B cell lymphoma: the phase 2, single-arm ZUMA-14 trial.

Paolo Strati et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.